Spotlight: (Original article published in Journal of Hematology & Oncology https://t.co/JYk5HVUhTi) #Tcell #CAR #clinicaltrial https://t.co/826CqSkJnn
2,759 followers
11,724 followers
A Phase I, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed against B Cell Maturation Antigen, in Patients with Relapsed or Refractory Multiple Myeloma https://t.co/ofn5cRl2MZ
12 followers
This was presented at ASCO and ASH, data finally published!!! A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma https:
2,015 followers
RT @Myeloma_Doc: Phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against BCMA, shows impressive…